Post-transplant lymphoproliferative disorder (PTLD) is a potentially life-threatening, abnormal growth of lymphoid cells that often occurs following an organ transplant, propelled by a weakened immune system and frequently associated with the Epstein-Barr virus.
Hyperbaric oxygen therapy may promote wound healing and immune response in Post-transplant lymphoproliferative disorder patients, potentially improving recovery times and quality of life.